[PHARMA] QoQ Annualized Quarter Result on 31-Mar-2015 [#1]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
18-May-2015
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2015
Quarter
31-Mar-2015 [#1]
Profit Trend
QoQ- 35.52%
YoY- 21.27%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
Revenue 2,189,312 2,012,216 1,969,498 1,887,616 2,122,933 1,994,440 1,987,488 6.64%
PBT 112,722 118,673 127,336 154,448 125,580 116,968 125,562 -6.92%
Tax -28,138 -27,282 -30,200 -26,744 -31,355 -40,162 -40,356 -21.31%
NP 84,584 91,390 97,136 127,704 94,225 76,805 85,206 -0.48%
-
NP to SH 84,044 90,642 96,022 127,176 93,844 76,196 84,384 -0.26%
-
Tax Rate 24.96% 22.99% 23.72% 17.32% 24.97% 34.34% 32.14% -
Total Cost 2,104,728 1,920,825 1,872,362 1,759,912 2,028,708 1,917,634 1,902,282 6.95%
-
Net Worth 529,482 534,070 527,991 528,173 525,526 507,513 502,162 3.58%
Dividend
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
Div 77,674 79,389 72,469 72,494 72,486 55,239 41,415 51.90%
Div Payout % 92.42% 87.59% 75.47% 57.00% 77.24% 72.50% 49.08% -
Equity
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
Net Worth 529,482 534,070 527,991 528,173 525,526 507,513 502,162 3.58%
NOSH 258,915 258,880 258,819 258,908 258,880 258,935 258,846 0.01%
Ratio Analysis
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
NP Margin 3.86% 4.54% 4.93% 6.77% 4.44% 3.85% 4.29% -
ROE 15.87% 16.97% 18.19% 24.08% 17.86% 15.01% 16.80% -
Per Share
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
RPS 845.57 777.28 760.95 729.07 820.05 770.25 767.82 6.62%
EPS 32.46 35.01 37.10 49.12 36.25 29.43 32.60 -0.28%
DPS 30.00 30.67 28.00 28.00 28.00 21.33 16.00 51.88%
NAPS 2.045 2.063 2.04 2.04 2.03 1.96 1.94 3.56%
Adjusted Per Share Value based on latest NOSH - 258,908
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
RPS 151.90 139.62 136.65 130.97 147.30 138.38 137.90 6.63%
EPS 5.83 6.29 6.66 8.82 6.51 5.29 5.85 -0.22%
DPS 5.39 5.51 5.03 5.03 5.03 3.83 2.87 52.04%
NAPS 0.3674 0.3706 0.3663 0.3665 0.3646 0.3521 0.3484 3.59%
Price Multiplier on Financial Quarter End Date
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
Date 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 -
Price 6.36 6.50 7.13 6.00 4.58 4.63 4.61 -
P/RPS 0.75 0.84 0.94 0.82 0.56 0.60 0.60 15.99%
P/EPS 19.59 18.56 19.22 12.21 12.63 15.73 14.14 24.20%
EY 5.10 5.39 5.20 8.19 7.91 6.36 7.07 -19.51%
DY 4.72 4.72 3.93 4.67 6.11 4.61 3.47 22.69%
P/NAPS 3.11 3.15 3.50 2.94 2.26 2.36 2.38 19.46%
Price Multiplier on Announcement Date
31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 30/09/14 30/06/14 CAGR
Date 15/02/16 26/11/15 17/08/15 18/05/15 23/02/15 21/11/14 21/08/14 -
Price 6.19 6.50 5.65 6.91 5.28 4.45 4.62 -
P/RPS 0.73 0.84 0.74 0.95 0.64 0.58 0.60 13.92%
P/EPS 19.07 18.56 15.23 14.07 14.57 15.12 14.17 21.82%
EY 5.24 5.39 6.57 7.11 6.87 6.61 7.06 -17.97%
DY 4.85 4.72 4.96 4.05 5.30 4.79 3.46 25.17%
P/NAPS 3.03 3.15 2.77 3.39 2.60 2.27 2.38 17.41%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment